MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)
Clinical trial NCT00797667 · TERMINATED
Trial details
- NCT number
- NCT00797667
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-12
- Primary completion
- 2009-05-20
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.